Autoimmune diseases: Are markers ready for prediction?

Journal of Clinical Investigation

Volumn 108, Issue 8, 2001, Pages 1091-1096

  Lernmark, A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ATROPHIC GASTRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CROHN DISEASE; DIABETES MELLITUS; HASHIMOTO DISEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THYROID DISEASE; TUMOR IMMUNITY;

AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BIOLOGICAL MARKERS; HUMANS; ORGAN SPECIFICITY;

EID: 0034777225     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200114234     Document Type: Review

References (9)

1. The World Health Organization International Collaborative Study for islet cell antibodies
2. Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: Report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell assays in type 1 diabetes
3. Epidemiology and estimated population burden of selected autoimmune diseases in the United States
4. Autoimmune diseases
5. Molecular mimicry and autoimmunity
6. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop
7. Prevention of type 1 diabetes